Pulmonary hypertension MRI

Jump to: navigation, search

Pulmonary Hypertension Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Pulmonary hypertension from other Diseases

Epidemiology & Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History & Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Right heart catheterization

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Pulmonary hypertension MRI On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Google Images

American Roentgen Ray Society Images of Pulmonary hypertension MRI

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Pulmonary hypertension MRI

CDC on Pulmonary hypertension MRI

Pulmonary hypertension MRI in the news

Blogs on Pulmonary hypertension MRI

Directions to Hospitals Treating Pulmonary hypertension

Risk calculators and risk factors for Pulmonary hypertension MRI

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1], Assistant Editor(s)-in-Chief: Ralph Matar

Overview

Cardiac MRI provides important prognostic indicators regarding the function of right ventricle in patients with pulmonary hypertension.

MRI

Role of MRI

The role of MRI:[1][2][3][4][5]

  • Accurate evaluation of the size, morphology and function of the right ventricle.
    • MRI has similar abilities to those of echocardiography in the diagnosis and treatment of patients with pulmonary hypertension.
  • Detection of shunts contributing to pulmonary hypertension.
  • Follow-up for right heart hemodynamics.
    • Poor right ventricular function is indicated by the following according to the ACCF/AHA 2009 expert consensus document on pulmonary hypertension:
  • Pulmonary artery stiffness measured by relative cross sectional area change ≤16% also has implications on mortality rate.

MRI Limitations include

  • Inability to perform breath hold
  • Limited availability and cost
  • Difficulty in assessing PA pressures

References

  1. Alassas K, Mergo P, Ibrahim e, Burger C, Safford R, Parikh P, Shapiro B (January 2014). "Cardiac MRI as a diagnostic tool in pulmonary hypertension". Future Cardiol. 10 (1): 117–30. doi:10.2217/fca.13.97. PMID 24344668. Vancouver style error: initials (help)
  2. Lungu A, Wild JM, Capener D, Kiely DG, Swift AJ, Hose DR (September 2014). "MRI model-based non-invasive differential diagnosis in pulmonary hypertension". J Biomech. 47 (12): 2941–7. doi:10.1016/j.jbiomech.2014.07.024. PMID 25145313.
  3. Ohira H, Beanlands RS, Davies RA, Mielniczuk L (February 2015). "The role of nuclear imaging in pulmonary hypertension". J Nucl Cardiol. 22 (1): 141–57. doi:10.1007/s12350-014-9960-y. PMID 25161042.
  4. Kreitner KF, Wirth GM, Krummenauer F, Weber S, Pitton MB, Schneider J, Mayer E, Dueber C (September 2013). "Noninvasive assessment of pulmonary hemodynamics in patients with chronic thromboembolic pulmonary hypertension by high temporal resolution phase-contrast MRI: correlation with simultaneous invasive pressure recordings". Circ Cardiovasc Imaging. 6 (5): 722–9. doi:10.1161/CIRCIMAGING.112.000276. PMID 23863980.
  5. Wirth G, Brüggemann K, Bostel T, Mayer E, Düber C, Kreitner KF (August 2014). "Chronic thromboembolic pulmonary hypertension (CTEPH) - potential role of multidetector-row CT (MD-CT) and MR imaging in the diagnosis and differential diagnosis of the disease". Rofo. 186 (8): 751–61. doi:10.1055/s-0034-1366425. PMID 24756429.

Linked-in.jpg